InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
8
T+90 hit rate
50%
T+90 mean return
+0.8%
Across 8 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Huizenga Theodore Alan, Vice-Président Senior, Directeur Comptable. Director active across 1 company, notably Ultragenyx Pharmaceutical Inc.. Cumulatively, 22 filings have been published. Split: 0 buy · 8 sells. Total volume traded: €232k. History available since 6 May 2021. The latest transaction was disclosed on 1 March 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations22 total
9,392 shares0Common StockSEC:0000950170-25-032764:0
648 shares0Common StockSEC:0000950170-24-135525:0
700 shares0Common StockSEC:0000950170-24-107677:0
▼
91 shares@ US$56.191.4% of flowCommon StockSEC:0000950170-24-103807:0
●
14 shares@ US$42.310.2% of flowCommon StockSEC:0000950170-24-045670:0
13,950 shares0Common StockSEC:0000950170-24-026641:0
1,000 shares0Common StockSEC:0001209191-24-000070:0
◇
2,000 shares@ US$21.0011.9% of flowCommon StockSEC:0001209191-23-048905:0
▼
883 shares@ US$37.049.1% of flowCommon StockSEC:0001209191-23-048489:0
◇
3,000 shares@ US$21.0017.4% of flowCommon StockSEC:0001209191-23-028585:0
●
14 shares@ US$38.200.1% of flowCommon StockSEC:0001209191-23-024685:0
7,590 shares0Common StockSEC:0001209191-23-016045:0
▼
639 shares@ US$43.407.9% of flowCommon StockSEC:0001209191-23-014502:0
▼
2,031 shares@ US$43.9625.5% of flowCommon StockSEC:0001209191-22-062400:0
1,000 shares0Common StockSEC:0001209191-22-049222:0
▼
132 shares@ US$84.550.0004% mcap11.8% of flowCommon StockSEC:0001209191-22-024699:0
▼
843 shares@ US$66.620.0020% mcap57.5% of flowCommon StockSEC:0001209191-22-015819:0
819 shares0Common StockSEC:0001209191-21-060756:0
819 shares0Common StockSEC:0001209191-21-060756
▼
142 shares@ US$113.670.0005% mcap15.3% of flowCommon StockSEC:0001209191-21-031386:0
▼
142 shares@ US$113.6715.3% of flowCommon StockSEC:0001209191-21-031386
1,000 sharesCommon StockSEC:0001562180-16-001338:0
22 of 22 declarations
About Huizenga Theodore Alan
Theodore Alan Huizenga is the Senior VP and Chief Accounting Officer at Ultragenyx Pharmaceutical Inc. He oversees the company's accounting operations, ensuring compliance and efficiency in financial processes. His expertise is essential in supporting growth strategy and ensuring the financial health of the organization.
